Kenneth Hoberman
CIK 1573722 · Chief Operating Officer · last filed 2025-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.27M
Companies
3
Total Filings
53
Lifetime Open-Market Net
-$5.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 5 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-07-08 | TGTX | Grant (A) | +12,459 | $0 | EDGAR |
| 2016-03-10 | STEMLINE THERAPEUTICS INC (STML) Delisted | Sell (S) | −2,412 | -$12.9K | EDGAR |
| 2016-02-26 | STEMLINE THERAPEUTICS INC (STML) Delisted | Grant (A) | +87,985 | $0 | EDGAR |
| 2016-02-19 | STEMLINE THERAPEUTICS INC (STML) Delisted | Sell (S) | −1,503 | -$6.8K | EDGAR |
| 2016-01-11 | STEMLINE THERAPEUTICS INC (STML) Delisted | Grant (A) | +150,000 | $0 | EDGAR |
| 2015-12-31 | STEMLINE THERAPEUTICS INC (STML) Delisted | Gift (G) | −60,000 | $0 | EDGAR |
| 2015-06-05 | TGTX | Grant (A) | +4,667 | $0 | EDGAR |
| 2015-03-20 | STEMLINE THERAPEUTICS INC (STML) Delisted | Mixed | +9,798 | -$173.5K | EDGAR |
| 2015-03-10 | STEMLINE THERAPEUTICS INC (STML) Delisted | Grant (A) | +24,379 | $0 | EDGAR |
| 2015-02-20 | STEMLINE THERAPEUTICS INC (STML) Delisted | Sell (S) | −1,593 | -$22.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.